These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14808241)

  • 1. Persistence of neutralizing antibody for a year following vaccination of monkeys with Lansing poliomyelitis virus.
    MORGAN IM
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):305-8. PubMed ID: 14808241
    [No Abstract]   [Full Text] [Related]  

  • 2. Formation of neutralizing antibody in monkeys injected with poliomyelitis virus and adjuvants.
    WARD R; RADER D; LIPTON MM; FREUND J
    Proc Soc Exp Biol Med; 1950 Jul; 74(3):536-9. PubMed ID: 15440879
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure to demonstrate antibody in feces of monkeys vaccinated with poliomyelitis virus, Lansing strain.
    AINSLIE JD; McCALLUM JL; FRANCIS T
    Proc Soc Exp Biol Med; 1950 Dec; 75(3):699-703. PubMed ID: 14808371
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular immunity of monkeys versus antibody titers following oral inoculation with poliomyelitis virus.
    BACHTOLD JG; GEBHARDT LP; WILCOX WC; BUBEL HC
    J Immunol; 1955 Dec; 75(6):475-7. PubMed ID: 13271772
    [No Abstract]   [Full Text] [Related]  

  • 5. Age incidence and seasonal development of neutralizing antibodies to lansing poliomyelitis virus.
    TURNER TB; HOLLANDER DH; BUCKLEY S; KOKKO UP; WINSOR CP
    Am J Hyg; 1950 Nov; 52(3):323-47. PubMed ID: 14789759
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralizing antibody to viruses of poliomyelitis in sera of domestic animals.
    BARTELL P; KLEIN M
    Proc Soc Exp Biol Med; 1955 Dec; 90(3):597-601. PubMed ID: 13289848
    [No Abstract]   [Full Text] [Related]  

  • 7. Virus and host factors influencing the titer of Lansing poliomyelitis virus in monkeys, cotton rats and mice.
    BODIAN D; MORGAN IM; SCHWERDT CE
    Am J Hyg; 1950 Jan; 51(1):126-33, illust. PubMed ID: 15401867
    [No Abstract]   [Full Text] [Related]  

  • 8. A specific complement-fixation test for infection with poliomyelitis virus.
    CASALS J; OLITSKY PK; ANSLOW RO
    J Exp Med; 1951 Aug; 94(2):123-37. PubMed ID: 14861374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative neutralizing antibody patterns to Lansing (type 2) poliomyelitis virus in different populations.
    PAUL JR; MELNICK JL; RIORDAN JT
    Am J Hyg; 1952 Nov; 56(3):232-51. PubMed ID: 12996493
    [No Abstract]   [Full Text] [Related]  

  • 10. Lansing poliomyelitis virus neutralizing antibody titers of different types of human serum.
    LEVINSON SO; MILZER A; WOLF AM
    Ill Med J; 1951 Oct; 100(4):238-40. PubMed ID: 14873311
    [No Abstract]   [Full Text] [Related]  

  • 11. Level of serum antibody associated with intracerebral immunity in monkeys vaccinated with Lansing poliomyelitis virus.
    MORGAN IM
    J Immunol; 1949 Jul; 62(3):301-10. PubMed ID: 18132343
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic classification of poliomyelitis viruses. II. Results obtained with the method for testing resistance of monkeys immunized with prototype viruses. B. Studies from the University of Utah on fifteen strains.
    GEBHARDT LP; BACHTOLD JG; WOODIE JD; LIAO SJ; WILCOX W
    Am J Hyg; 1951 Sep; 54(2):211-5. PubMed ID: 14877801
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic classification of poliomyelitis viruses. II. Results obtained with the method for testing resistance of monkeys immunized with prototype viruses. A. Studies from the University of Southern California on twenty-three strains.
    KESSEL JF; PAIT CF; KOKKO UP
    Am J Hyg; 1951 Sep; 54(2):205-10. PubMed ID: 14877800
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sero-neutralizing antibodies against poliomyelitis virus II (Lansing) in inhabitants of Bucharest].
    CAJAL N; LISSIEVICI-OPRESCU E
    Stud Cercet Inframicrobiol; 1956; 7(1-2):57-63. PubMed ID: 13380643
    [No Abstract]   [Full Text] [Related]  

  • 15. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 16. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 17. STANDARDIZATION OF POLIOMYELITIS IMMUNE GLOBULIN.
    UHLENDORF BW; BROWN ER; FABISCH PH; HOTTLE GA
    J Immunol; 1964 May; 92():806-10. PubMed ID: 14170423
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period; the ratio of inapparent infection to clinical poliomyelitis.
    MELNICK JL; LEDINKO N
    Am J Hyg; 1953 Sep; 58(2):207-22. PubMed ID: 13080261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Variations in the neutralizing antibodies for 3 types of poliomyelitis virus following inoculation of inactivated vaccine].
    MAJORI L; GASPARINI V
    Riv Ist Sieroter Ital; 1959; 34():237-50. PubMed ID: 14420105
    [No Abstract]   [Full Text] [Related]  

  • 20. [Poliovirus infection in monkeys vaccinated with live Sabin vaccine].
    Beĭkin IaB; Erman BA; Vlasova LV; Vaserin IuI; Livshits AA
    Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):84-9. PubMed ID: 6249057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.